PD Dr. Benjamin Frey

Medizinische Fakultät Department of Radiation Oncology

Low Dose Radiation Therapy Induces Long-Lasting Reduction of Pain and Immune Modulations in the Peripheral Blood - Interim Analysis of the IMMO-LDRT01 Trial (2021) Donaubauer AJ, Becker I, Weissmann T, Fröhlich B, Munoz LE, Gryc T, Denzler M, et al. Journal article Reduction of elective radiotherapy treatment volume in definitive treatment of locally advanced head and neck cancer—comparison of a prospective trial with a revised simulated contouring approach (2021) Weissmann T, Speer S, Putz F, Lettmaier S, Schubert P, Shariff M, Semrau S, et al. Journal article Transcriptomes of MPO-deficient patients with generalized pustular psoriasis reveals expansion of CD4+cytotoxic T cells and an involvement of complement system and interferon pathways (2021) Hüffmeier U, Frey B, Becker I, Atreya I, Berking C, Moessner R, Wilsmann-Theis D, et al. Conference contribution Chromosome aberrations in lymphocytes of patients undergoing radon spa therapy: An explorative mfish study (2021) Paz N, Hartel C, Nasonova E, Donaubauer AJ, Frey B, Ritter S Journal article Innovative radiation oncology Together - Precise, Personalized, Human Vision 2030 for radiotherapy & radiation oncology in Germany (2021) Krug D, Hecht M, Ebert N, Maeurer M, Fleischmann DF, Fokas E, Straube C, et al. Journal article Hypofractionated Radiotherapy Upregulates Several Immune Checkpoint Molecules in Head and Neck Squamous Cell Carcinoma Cells Independently of the HPV Status While ICOS-L Is Upregulated Only on HPV-Positive Cells (2021) Wimmer S, Deloch L, Hader M, Derer A, Grottker F, Weissmann T, Hecht M, et al. Journal article Graphene-Induced Hyperthermia (GIHT) Combined With Radiotherapy Fosters Immunogenic Cell Death (2021) Podolska M, Shan X, Janko C, Boukherroub R, Gaipl U, Szunerits S, Frey B, Munoz LE Journal article Editorial to radiation in multimodal tumor immune therapies—mechanisms and application (2021) Frey B, Gaipl U Journal article Longitudinal C-reactive protein (CRP) as an individualized dynamic predictor for metastatic cancer patients treated with immune checkpoint inhibitors: Findings from the prospective ST-ICI cohort. (2021) Zhou JG, Ma H, Gaipl U, Frey B, Hecht M, Fietkau R Conference contribution Primary Results of the phase II CheckRad-CD8 Trial: First-Line Treatment of locally advanced Head and Neck Tumors with double Checkpoint Blockade and Radiotherapy dependent on intratumoral CD8+T-Cell Infiltration (2021) Hecht M, Eckstein M, Rutzner S, Von Der Gruen J, Illmer T, Klautke G, Laban S, et al. Conference contribution